Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page update is limited to a revision label change from v3.4.1 to v3.4.2 and does not modify study content, eligibility criteria, contacts, or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page shows a minor system revision from v3.4.0 to v3.4.1; no user-facing study details or eligibility information were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays a 'Last Update Posted' label, replacing the previous 'Last Update Posted (Estimated)' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. These changes reflect the page's version history rather than any modification to study details or eligibility.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with California and Georgia, reorganizing location information. Removed the HHS Vulnerability Disclosure link and updated the revision to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision information on the page was updated to v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.